Assessment of clinical characteristics of cardiac amyloidosis as a potential underlying etiology in patients diagnosed with heart failure with preserved ejection fraction

Murat S., Cavusoglu Y., Yalvac H. E., Sivrikoz İ., Kocagil S.

KARDIOLOGIA POLSKA, vol.80, no.6, pp.672-678, 2022 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 80 Issue: 6
  • Publication Date: 2022
  • Doi Number: 10.33963/kp.a2022.0098
  • Journal Name: KARDIOLOGIA POLSKA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
  • Page Numbers: pp.672-678
  • Keywords: cardiac amyloidosis, diastolic heart failure, heart failure with preserved ejection fraction, red flags, transthyretin, WILD-TYPE TRANSTHYRETIN, ESC GUIDELINES, ECHOCARDIOGRAPHY, HYPOTENSION, DISEASE, UPDATE
  • Eskisehir Osmangazi University Affiliated: Yes

Abstract

Background: Heart failure with preserved ejection fraction (HFpEF) is heterogeneous clinical syndrome. Transthyretin cardiac amyloidosis (CA) is an underdiagnosed cause of HFpEF. Red flags are extremely useful for suspecting CA.